Coeptis Therapeutics Inc. (COEP) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Coeptis Therapeutics Inc.

    NASDAQ: COEP · Real-Time Price · USD
    17.00
    0.38 (2.29%)
    At close: Oct 03, 2025, 3:59 PM
    17.34
    2.00%
    After-hours: Oct 03, 2025, 04:57 PM EDT

    Coeptis Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.08 -18.94 -11.65 -15.2
    PEG Ratio
    		 -0.00 0.27 0.15 -0.01
    PS Ratio
    		 n/a n/a n/a 2.73K
    PB Ratio
    		 3.32 494.89 91.16 86.96
    P/FCF Ratio
    		 -1.59 -55.64 -112.98 -32.76
    P/OCF Ratio
    		 -1.59 -55.64 -112.98 -45.53
    OCF/S Ratio
    		 n/a n/a n/a -59.86
    Debt / Equity Ratio
    		 0.44 1.50 0.36 1.74
    Quick Ratio
    		 0.23 0.59 2.16 0.79
    Current Ratio
    		 0.23 0.59 2.16 0.79
    Asset Turnover
    		 n/a n/a n/a 0.01
    Interest Coverage
    		 -25.38 198.99 -156.57 -75.06
    Return on Equity
    		 -3.08 -26.13 -7.82 -5.72
    Return on Assets
    		 -1.1 -4.65 -4.75 -1.99
    Return on Invested Capital
    		 -1.61 -8.28 -4.48 -2.18
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a -4.96
    Net Profit Margin
    		 n/a n/a n/a -179.32
    Pretax Profit Margin
    		 n/a n/a n/a -179.32
    Operating Profit Margin
    		 n/a n/a n/a -187.28
    FCF Margin
    		 n/a n/a n/a -83.19
    EBITDA Margin
    		 n/a n/a n/a -170.87

    Add to Watchlist